Medication info
Candero-Tan Plus Tablets

Candero-Tan Plus Tablets

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
White rectangular tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201007774 · Notified 2010.12.31 · Insurance code 642903960

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
The recommended dose of this medication is 1 tablet once daily, taken with or without food. 1) Adults: Before switching to this medication, the dose of candesartan cilexetil should first be adjusted. When clinically appropriate, direct conversion from monotherapy to this medication may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medication is necessary in elderly patients. 3) Patients with intravascular volume depletion: Adjustment of the candesartan cilexetil dose is recommended in patients at risk of hypotension, such as those who may have reduced effective circulating blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medication (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, it is recommended that the dose of candesartan cilexetil be adjusted before administering this medication (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension, which is difficult to achieve sufficient effects with individual components alone. In other words, when blood pressure control is challenging with monotherapy, this medication helps to effectively lower and control blood pressure. Essential hypertension increases the risk of cardiovascular complications if blood pressure is not consistently managed, making this medication crucial for safe and effective blood pressure management.

How to take

Adult dose

The recommended dose of this medication is 1 tablet once daily, taken with or without food. 1) Adults: Before switching to this medication, the dose of candesartan cilexetil should first be adjusted. When clinically appropriate, direct conversion from monotherapy to this medication may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medication is necessary in elderly patients. 3) Patients with intravascular volume depletion: Adjustment of the candesartan cilexetil dose is recommended in patients at risk of hypotension, such as those who may have reduced effective circulating blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medication (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, it is recommended that the dose of candesartan cilexetil be adjusted before administering this medication (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This drug can cause serious harm to the fetus and newborn if taken during pregnancy, especially during the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to the ingredients in this drug or sulfonamide derivatives should not take it. Patients with severe kidney or liver impairment, a history of specific angioedema, gout, hyponatremia, hypokalemia, or hypercalcemia should not use this drug. Patients with reduced blood volume or electrolyte imbalance, patients at risk for hepatic coma, and those with heart valve disease should use this drug cautiously. This drug may cause mild side effects such as headaches, dizziness, nausea, and fatigue, and serious adverse reactions such as blood disorders, liver function abnormalities, and skin rashes may occur infrequently. It is important to regularly check blood pressure, kidney function, and electrolyte levels during the use of this drug to ensure there are no abnormalities. Interactions with other antihypertensives, diuretics, potassium supplements, etc., may increase the risk of side effects, so it is recommended to consult with the attending physician or pharmacist. This drug may be secreted in breast milk, so breastfeeding should be discontinued or a physician should be consulted if breastfeeding. Safety in children under 18 years has not been established, so caution in use is necessary. Elderly patients should take this drug cautiously to avoid excessively low blood pressure, which can burden the heart or kidneys. In case of overdose, symptoms such as hypotension, electrolyte imbalance, and dizziness may occur; seek medical attention immediately for appropriate treatment. Store this medication out of reach of children and keep it in its original container to prevent misuse or degradation in quality. When driving or operating machinery, caution is needed as dizziness or fatigue may occur.

Side effects

  • Headache
  • back pain
  • dizziness
  • respiratory tract infection
  • symptoms similar to influenza
  • sinusitis
  • bronchitis
  • urinary tract infection
  • nausea
  • contusion
Show 74 more
  • tachycardia
  • fatigue
  • abdominal pain
  • pharyngitis
  • atrioventricular block
  • vomiting
  • dyslipidemia
  • rhinitis
  • cough
  • increased blood sugar
  • increased serum uric acid
  • elevated ALT
  • decreased hemoglobin
  • increased serum AST
  • increased creatinine
  • elevated urea
  • increased potassium
  • decreased sodium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • dizziness
  • intestinal vascular edema
  • diarrhea
  • renal failure
  • angioedema
  • rash
  • urticaria
  • pruritus
  • arthralgia
  • myalgia
  • hyperkalemia
  • hyponatremia
  • elevated liver enzymes
  • abnormal liver function
  • hepatitis
  • increased cholesterol
  • increased triglycerides
  • venous thrombosis
  • sensory disturbances
  • transient blurred vision
  • choroidal exudate
  • acute myopia
  • acute angle-closure glaucoma
  • dyspnea
  • acute respiratory distress syndrome
  • loss of appetite
  • appetite loss
  • gastrointestinal irritation
  • constipation
  • pancreatitis
  • interstitial nephritis
  • rash
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus erythematosus-like reaction
  • activation of lupus erythematosus
  • muscle cramps
  • hyperglycemia
  • hyperuricemia
  • electrolyte imbalance
  • orthostatic hypotension
  • necrotizing vasculitis
  • weakness
  • fever
  • anaphylactic reaction
  • jaundice
  • sleep disorders
  • depression
  • agitation
  • edema
  • myalgia
  • hypercalcemia
  • pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White rectangular tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.